Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/22/2008CN101288661A Fenticonazole nitrate vaginal effervescent tablets and preparation method thereof
10/22/2008CN101288660A Levonorgestrel drop pills and preparation method thereof
10/22/2008CN101288658A Compound ambroxol sustained-release drop pills and preparation method thereof
10/22/2008CN101288657A Troxerutin-cumarin sustained-release drop pills and preparation method thereof
10/22/2008CN101288656A Spironolactone sustained-release drop pills and preparation method thereof
10/22/2008CN101288655A Itraconazole sustained-release drop pills and preparation method thereof
10/22/2008CN101288653A Methylphenidate hydrochloride sustained-release floating micropill in stomach and its preparation method
10/22/2008CN101288651A Compound glycyrrhizin dispersible tablet and preparation method thereof
10/22/2008CN101288650A Edaravone lyophilized preparation and preparation technique thereof
10/22/2008CN101288649A Preparation technique of sodium phosphocreatine powder and injection preparation
10/22/2008CN101288648A Easy-to-administrate oxiracetam granular formulation and preparation method
10/22/2008CN101288645A Tilidine medicine resin oral turbid suspension and preparation method thereof
10/22/2008CN101288644A Ginkgo bilobate extract injections and preparation method thereof
10/22/2008CN101288643A Gel composition containing tacrolimu and its preparation method and medicinal application
10/22/2008CN101288642A Taxanes medicine preparation for intravenous injection and preparation method thereof
10/22/2008CN101288641A Coenzyme Q10 water dispersion and preparation method thereof
10/22/2008CN100427499C Soluble salt of azithromycin and its preparation process
10/22/2008CN100427486C Novel benzimidazole derivatives
10/22/2008CN100427485C Process of preparing sophoridine, oxidized sophoridine and salts from sophora alopecuroide
10/22/2008CN100427484C 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts
10/22/2008CN100427482C N,N-dimethylaminoacyl-2,3-difuryl-6-aminoquinoxaline, preparation method and application thereof
10/22/2008CN100427479C Photochromic perfluoro cyclopentene diaryl ethylene schiff base compound, and its preparing method and use
10/22/2008CN100427475C Naproxen-2-aryl morpholine ethyl ester and its preparation method and uses
10/22/2008CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/22/2008CN100427465C N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
10/22/2008CN100427143C Solid preparation
10/22/2008CN100427135C Composition of Chinese traditional medicine preparation method, and quality control method
10/22/2008CN100427133C Externally applied medicine for cutting therapy
10/22/2008CN100427121C Resina draconis and its total flavone solution preparation and its preparation method
10/22/2008CN100427118C Burn and scald medicine
10/22/2008CN100427115C Effective ingredients of Chinese medicine moutan bark and preparation method thereof
10/22/2008CN100427109C Preparation of compound puerarin
10/22/2008CN100427100C Topical blood pressure composition
10/22/2008CN100427099C Juglans mandshurica maxim pdysaccharide preparation capable of effectively treating brain cancer and its preapring method
10/22/2008CN100427098C Erigeron breviscapus dispersion tablet
10/22/2008CN100427097C Parenteral formulation of mycophenolic acid, a salt or prodrug thereof.
10/22/2008CN100427096C Method for preparing suspension of rhodiola root nanoliposome
10/22/2008CN100427095C Injection for venocylsis of diluted Diltiazem containing calcium channel blocker
10/22/2008CN100427094C Usage of alpha-(Morpholin-1-base) methyl-2-methyl-5-azathio-1-alcohol in preparation of anti-trichomoniasis and anti-ameba medicines
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/22/2008CN100427092C Agent for derivating metamorphosis of sea cyphonaute larva based on information transfer, and its application
10/22/2008CN100427091C Gatiflxacin eye gels based on HPMC medium and its preparing method
10/22/2008CN100427090C Compound prescription of Chinese medicinal effective ingredients having anti-neovascularization synergetic effect
10/22/2008CN100427089C Use of indazole derivatives for the treatment of neuropathic pain
10/22/2008CN100427088C Paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral cavity disintegration tablet for treating cold and preparation method thereof
10/22/2008CN100427087C Pharmaceutical composition containing oxidized sophoridine or its salt, its preparation method and uses
10/22/2008CN100427086C Dripping pills for treating cardiac arrhythmia and its preparation
10/22/2008CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/22/2008CN100427084C Oral silybin sustained release agent and preparation thereof
10/22/2008CN100427083C Method for preparing flavone aglycone micro capsule
10/22/2008CN100427082C Application of hydroxybenzoate acid and its analogue in the preparing process of medicine for preventing and treating virus infection
10/22/2008CN100427081C Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
10/22/2008CN100427080C Enteroclysis contg. sodium azulene-sulfonate
10/22/2008CN100427079C Vaginal foam preparation of chlorhexidine acetate and its preparing process
10/22/2008CN100427078C Decanoyl acetaldehyde compound and its medicinal composition
10/22/2008CN100427071C Cold treating dripping pills and its preparation method
10/22/2008CN100427063C An wind-expelling ointment and method for preparing same
10/22/2008CN100427049C Intrauterine device containing progesterone with no bracket
10/22/2008CN100426980C Oral veterinary drug delivery system and/or feed additive delivery system, process for the preparation and use thereof
10/21/2008US7439398 Prepared from racemic tomoxetine; also provides enantiomerically pure atomoxetine HCl prepared from (R)-(-)-tomoxetine (S)-(+)-mandelate; selective norepinephrine reuptake inhibitor; high enantiomeric purity, efficiency; Attention-Deficit/Hyperactivity Disorder (ADHD)
10/21/2008US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis
10/21/2008US7439394 Cyclohexyl-1,4-diamine compounds
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439383 Sodium channel blockers
10/21/2008US7439374 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/21/2008US7439372 Therapeutic compounds
10/21/2008US7439370 Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
10/21/2008US7439367 Catalytic oxidation of sulfinyl compound; gastric ulcers; lansoprazole, omeprazole, pantoprazole, rabeprazole
10/21/2008US7439363 Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors
10/21/2008US7439362 For treatment of acne, seborrhea, androgenic alopecia. hirsutism, and breast cancer
10/21/2008US7439360 Vanilloid receptor ligands and their use in treatments
10/21/2008US7439359 Antiproliferative agents; antitumor agents; binding to chaperone protein
10/21/2008US7439358 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
10/21/2008US7439356 Substituted indan derivatives
10/21/2008US7439355 Process for the production of oxabispidines
10/21/2008US7439349 Method for preparation of large volume batches of poly-ICLC with increased biological potency; therapeutic, clinical and veterinary uses thereof
10/21/2008US7439344 One step
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439335 Synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders
10/21/2008US7439271 Reduction of hair growth
10/21/2008US7439270 Drugs for spinal anesthesia
10/21/2008US7439269 application of moisturizer to nasal cavity may facilitate and/or promote healthy function of the cavity, which in turn may reduce the duration of symptoms associated with a common cold or the flu; comprising: purified water; a hydrophilic thickener; and an encapsulated moisturizing agent
10/21/2008US7439268 Compositions containing prodrugs of florfenicol and methods of use
10/21/2008US7439267 Administering to a patient a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester; cardiovascular disorders
10/21/2008US7439265 irciniastatins, essentially pure, isolated from Indo-Pacific marine sponge Ircinia ramosa by cancer cell line bioassay-guided techniques; isochromene-pyran derivatives; dichloromethane-methanol extract; anticarcinogenic agent; P388 lymphocytic leukemia and pancreas, breast, CNS, lung cancer cell lines
10/21/2008US7439264 Therapeutic compounds
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439262 Serotonergic 5-HT2 agonists; chemical stability; topical; length of therapeutic activity; 1-(2-Aminopropyl)-1H-indazole-6-carboxylic acid ethyl ester
10/21/2008US7439261 Process for the preparation of valsartan and intermediates thereof
10/21/2008US7439260 7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
10/21/2008US7439259 e.g. 2-{4-[({2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}-2-methylpropanoic acid; peroxime proliferator activated receptor inhibitor; antidiabetic, hypoglycemic agent; dyslipidemia, syndrome X, heart failure, hypercholesteremia, insulin resistance
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/21/2008US7439256 (Arylamidoaryl) cyanoguanidine compounds
10/21/2008US7439255 3-Endo)-3-(2-cyano-2,2-diphenylethyl)-8-(cyclohexylmethyl)-8-methyl-8-azoniabicyclo[3.2.1]octane bromide; smooth muscle relaxation; respiratory system disorders: asthma, COPD, chronic bronchitis, chronic bronchiolitis and emphysema
10/21/2008US7439254 Compounds, compositions, and methods
10/21/2008US7439253 for example: the triethylammonium salt of 5,6-dihydro-6-oxo-N2-phenyl-5(sulfoxy)-4H-4,7-methanopyrazolo[3,4-e][1,3]diazepine-2,8(8H)-dicarboxamide
10/21/2008US7439252 Ascomycin crystalline forms and preparation thereof
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
1 ... 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 ... 7860